132 related articles for article (PubMed ID: 11812373)
1. [The efficacy of p16, p53 and p21 genes on the proliferation of lung cancer cells in vitro].
Wen G; Li J; Zou G; Fan X; Rao W
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Mar; 22(3):169-72. PubMed ID: 11812373
[TBL] [Abstract][Full Text] [Related]
2. [Gene therapy with tumor suppressor gene p53 and(or) p16 on the nude mice models of NSCLC in vivo].
Wu W; Zhang X; Qi X
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jul; 23(7):403-5. PubMed ID: 11778504
[TBL] [Abstract][Full Text] [Related]
3. [Expression of tumor suppressor genes p16, p21 and p53 in a pair of lung adenocarcinoma cell lines with different metastasis potentials: Anip973 and AGZY83-a].
Wang B; Yan C; Wu Y; Gao H; Wang Q; Jin Y; Huang C; Zhang G; Fu S; Li P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):128-31. PubMed ID: 11295133
[TBL] [Abstract][Full Text] [Related]
4. Increased radiation-induced apoptosis and altered cell cycle progression of human lung cancer cell lines by antisense oligodeoxynucleotides targeting p53 and p21(WAF1/CIP1).
Sak A; Wurm R; Elo B; Grehl S; Pöttgen C; Stüben G; Sinn B; Wolf G; Budach V; Stuschke M
Cancer Gene Ther; 2003 Dec; 10(12):926-34. PubMed ID: 14712319
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer.
Joshi US; Chen YQ; Kalemkerian GP; Adil MR; Kraut M; Sarkar FH
Cancer Gene Ther; 1998; 5(3):183-91. PubMed ID: 9622102
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of tumor suppressor p53, p21, and p16 gene therapy effects on glioblastoma tumorigenicity in situ.
Wang TJ; Huang MS; Hong CY; Tse V; Silverberg GD; Hsiao M
Biochem Biophys Res Commun; 2001 Sep; 287(1):173-80. PubMed ID: 11549271
[TBL] [Abstract][Full Text] [Related]
7. Proliferation arrest in G1 phase of a non-small cell lung cancer cell line (NSCLC-N6) treated by an original compound methyl-4-methoxy-3-(3-methyl-2-butanoyl) benzoate (VT1) independently of the p53/p21 cascade.
Jacquot C; Moreau D; Tomasoni C; Juge M; Coiffard L; Roussis V; Roussakis C
Int J Oncol; 2003 Aug; 23(2):495-501. PubMed ID: 12851701
[TBL] [Abstract][Full Text] [Related]
8. Co-transfection of p16(INK4a) and p53 genes into the K562 cell line inhibits cell proliferation.
Rui HB; Su JZ
Haematologica; 2002 Feb; 87(2):136-42. PubMed ID: 11836163
[TBL] [Abstract][Full Text] [Related]
9. [Research on expression and control of p16 and p21 by wild-type p53 gene in two lung adenocarcinoma cell lines].
Jin Y; Yan CH; Wu Y; Liu Y; Zhang GY; Li P; Fu SB
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):409-12. PubMed ID: 14556194
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory effect of adenovirus-mediated p16INK4a gene transfer on the proliferation of lung cancer cell line.
Lee JH; Lee CT; Yoo CG; Hong YK; Kim CM; Han SK; Shim YS; Carbone DP; Kim YW
Anticancer Res; 1998; 18(5A):3257-61. PubMed ID: 9858892
[TBL] [Abstract][Full Text] [Related]
11. [Effect of exogenous p16 gene on the growth of wild-type p53 human lung adenocarcinoma cells].
Fu X; Zhang S; Ran R
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):102-4. PubMed ID: 11776846
[TBL] [Abstract][Full Text] [Related]
12. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
13. E1B-deleted adenovirus replicates in p53-deficient lung cancer cells due to the absence of apoptosis.
Harada N; Maniwa Y; Yoshimura M; Nagata M; Hamada H; Yokono K; Okita Y
Oncol Rep; 2005 Nov; 14(5):1155-63. PubMed ID: 16211279
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated p16INK4a gene expression radiosensitizes non-small cell lung cancer cells in a p53-dependent manner.
Kawabe S; Roth JA; Wilson DR; Meyn RE
Oncogene; 2000 Nov; 19(47):5359-66. PubMed ID: 11103937
[TBL] [Abstract][Full Text] [Related]
15. [Development and application of the method for controlling contamination of tumor samples with normal cells to detect deletion of P16 gene in primary lung carcinoma].
Ran R; Cao XA; Tian Y
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Jun; 20(3):136-40. PubMed ID: 10072815
[TBL] [Abstract][Full Text] [Related]
16. [Effect of exogenous p16 gene on biological behaviors of human lung cancer].
Bai M; Jin Y; Zhang X
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):465-8. PubMed ID: 11718035
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-controlled p53 gene therapy for human non-small cell lung cancer xenografts in athymic nude mice via the CArG elements.
Wang WD; Li R; Chen ZT; Li DZ; Duan YZ; Cao ZH
Cancer Sci; 2005 Oct; 96(10):706-12. PubMed ID: 16232203
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers.
Huang CL; Yokomise H; Miyatake A
Future Oncol; 2007 Feb; 3(1):83-93. PubMed ID: 17280505
[TBL] [Abstract][Full Text] [Related]
20. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients.
Boulay JL; Perruchoud AP; Reuter J; Bolliger C; Herrmann R; Rochlitz C
Cancer Gene Ther; 2000 Sep; 7(9):1215-9. PubMed ID: 11023193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
